We employed MOLM14, MV4-11 and THP1 representing well characterized models of MLL-driven leukaemia, KASUMI1 as a widely used line for RUNX1-ETO fusion, and FUJIOKA and KG1A cells as models for complex karyotype leukaemias. Here, KMT2A is linked to leukemia.